12 results on '"Jemielity, Marek"'
Search Results
2. Pre-procedural abnormal function of von Willebrand Factor is predictive of bleeding after surgical but not transcatheter aortic valve replacement
- Author
-
Grodecki, Kajetan, Zbroński, Karol, Przybyszewska-Kazulak, Elżbieta, Olasińska-Wiśniewska, Anna, Wilimski, Radosław, Rymuza, Bartosz, Scisło, Piotr, Czub, Paweł, Koper, Dominika, Kochman, Janusz, Pawlak, Katarzyna, Ciepiela, Olga, Grygier, Marek, Jemielity, Marek, Lesiak, Maciej, Filipiak, Krzysztof J., Opolski, Grzegorz, and Huczek, Zenon
- Published
- 2019
- Full Text
- View/download PDF
3. Long-term mortality after transcatheter aortic valve implantation for aortic stenosis in immunosuppressiontreated patients: a propensity-matched multicentre retrospective registry-based analysis.
- Author
-
Walczewski, Michał, Gąsecka, Aleksandra, Witkowski, Adam, Dabrowski, Maciej, Huczek, Zenon, Wilimski, Radosław, Ochała, Andrzej, Parma, Radosław, Rymuza, Bartosz, Grygier, Marek, Jemielity, Marek, Olasińska-Wiśniewska, Anna, Jagielak, Dariusz, Targoński, Radosław, Pastuszak, Krzysztof, Grešner, Peter, Grabowski, Marcin, and Kochman, Janusz
- Subjects
HEART valve prosthesis implantation ,AORTIC stenosis ,RETROSPECTIVE studies - Abstract
Introduction: Data regarding patients with a previous medical record of immunosuppression treatment who have undergone transcatheter aortic valve implantation (TAVI) are limited and extremely inconclusive. Available studies are mostly short term observations; thus there is a lack of evidence on efficacy and safety of TAVI in this specific group of patients. Aim: To compare the in-hospital and long-term outcomes between patients with or without a medical history of immunosuppressive treatment undergoing TAVI for aortic valve stenosis (AS). Material and methods: We conducted a retrospective registry-based analysis including patients undergoing TAVI for AS at 5 centres between January 2009 and August 2017. The primary endpoint was long-term all-cause mortality. Secondary endpoints comprised major vascular complications, life-threatening or disabling bleeding, stroke and new pacemaker implantation. Results: Of 1451 consecutive patients who underwent TAVI, two propensity-matched groups including 25 patients with a history of immunosuppression and 75 patients without it were analysed. No differences between groups in all-cause mortality were found in a median follow-up time of 2.7 years following TAVI (p = 0.465; HR = 0.73; 95% CI: 0.30-1.77). The rate of major vascular complications (4.0% vs. 5.3%) was similar in the two groups (p = 1.000). There were no statistically significant differences in the composite endpoint combining life-threatening or disabling bleeding, major vascular complications, stroke and new pacemaker implantation (40.0% vs. 20.0%, p = 0.218). Conclusions: Patients who had undergone TAVI for AS had similar long-term mortality regardless of whether they had a previous medical record of immunosuppression. Procedural complication rates were comparable between the groups. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Do we correctly calculate doses of cardioplegia during aortic valve replacement procedures? A preliminary report.
- Author
-
Sucharska, Aleksandra, Adamowska, Agnieszka, Karbowska, Zuzanna, Kumar, Lavanya Mohan, Pudełko, Jakub, Szarpak, Łukasz, Jemielity, Marek, and Perek, Bartłomiej
- Subjects
AORTIC valve transplantation ,INDUCED cardiac arrest ,TROPONIN I ,MYOCARDIAL injury ,AORTIC stenosis - Abstract
Introduction: Intraoperative myocardial protection during aortic valve replacement (AVR) for aortic stenosis (AS) is of paramount importance for outcomes. The dose of cardioplegia is usually calculated with reference to body mass. Aim: To assess whether such a strategy should be applied to all AS patients undergoing AVR. Material and methods: The study included 94 patients who underwent elective isolated AVR in cardiopulmonary bypass with cold cardioplegic arrest, with a mean age of 65.4 ±7.8 years. They were divided into two subgroup: A with an infusion of high (above median) and subgroup B with a low (below median) volume of cardioplegia indexed for left ventricular mass (LVM). Their doses were referred to the maximal postoperative release of cardiac troponin I (cTnI max). Eventually, it was examined whether the extent of intraoperative myocardial injury translated into long-term survival stratified according to the Kaplan-Meier method. Results: The mean volume of cardioplegia was 1381 ±279 ml (4.9 ±1.6 ml/g of LV myocardium). cTnI max was much higher in group A than in group B (medians: 14.918 vs. 9.876 µg/l; p = 0.005). Moreover, a negative correlation between the index cardioplegia volume and cTnI max (r = 0.345) was noted. The five-year probability of survival in subgroup A (95.7%) was significantly better than that in subgroup B individuals (82.6%, p = 0.044). Conclusions: Calculating cardioplegic doses during AVR solely based on body mass may be suboptimal and have a significant impact on postoperative outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Open-Heart Cardio-Thoracic Biological Valve Replacement Following Complicated Transcatheter Aortic Valve Implantation.
- Author
-
Klotzka, Aneta, Woźniak, Patrycja, Misterski, Marcin, Rodzki, Michał, Puślecki, Mateusz, Jemielity, Marek, Grygier, Marek, Araszkiewicz, Aleksander, Iwańczyk, Sylwia, and Buczkowski, Piotr
- Subjects
HEART valve prosthesis implantation ,AORTIC stenosis ,AORTIC valve insufficiency ,PULMONARY valve ,CARDIAC surgery ,VALVES ,HEART - Abstract
Transcatheter aortic valve implantation (TAVI) is currently becoming the method of choice in high-risk patients with severe aortic valve stenosis. Post-TAVI complications are more common owing to the increasing use of the method. The majority of TAVI complications derive from concomitant aortic stenosis with moderate/severe aortic insufficiency, paravalvular leak, and atrioventricular block. The contemporary TAVI qualification process includes a thorough echocardiography and angio-CT of the aorta, which is crucial in assessing valve measurements, determining the position of the coronary arteries branching from the aorta, and choosing the optimal valve size. We present the case report of an 81-year-old patient admitted to our hospital because of exacerbation of the clinical condition and development of pulmonary edema a few days after TAVI. Despite the reduction of the initial leak, an echocardiographic examination revealed the remaining severe paravalvular aortic leakage. We performed open-heart cardio-thoracic surgery, explanted the TAVI valve, and implanted the biological prosthesis (Edwards Perimount Magna size 25). Introduction of new interventional treatment approaches and the availability of imaging tools have substantially reduced the incidence of significant paravalvular leak and offered a better prognosis for patients undergoing TAVI. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Neutrophil-to-lymphocyte ratio as a predictor of inflammatory response in patients with acute kidney injury after transcatheter aortic valve implantation.
- Author
-
Olasińska-Wiśniewska, Anna, Urbanowicz, Tomasz, Grodecki, Kajetan, Perek, Bartłomiej, Grygier, Marek, Michalak, Michał, Misterski, Marcin, Puślecki, Mateusz, Rodzki, Michał, Stelmark, Konrad, Lesiak, Maciej, and Jemielity, Marek
- Subjects
HEART valve prosthesis implantation ,ACUTE kidney failure ,NEUTROPHIL lymphocyte ratio ,INFLAMMATION ,AORTIC valve insufficiency ,REFERENCE values - Abstract
Background. Persistent inflammatory response after transcatheter aortic valve implantation (TAVI) is one of the possible causes of early and mid-term postprocedural adverse events. Objectives. To establish the predictive role of whole blood parameters on inflammatory response characteristics within a 1-year follow-up. Materials and methods. The study group comprised 163 consecutive patients (52.1% females), mean age 78.6 (±6.6) years (± standard deviation (SD)) who underwent TAVI and completed 1-year follow-up on-site examinations. Patients were retrospectively divided into acute kidney injury (AKI) and non-AKI subgroups. Clinical and laboratory data were collected. In-hospital and follow-up outcomes were assessed. Results. The clinical and procedural details did not show significant differences between AKI and non-AKI groups. Neutrophil-to-lymphocyte ratio (NLR) decreased from baseline to measurement after 1 year with a statistically significant decline in the whole study population and non-AKI subgroup (both p = 0.005). The baseline NLR cutoff value of 4.2 for the non-AKI group ((area under the curve (AUC) = 0.718, p < 0.0001; sensitivity 46.27%, specificity 92.31%) and of 3.8 for the AKI group (AUC = 0.673, p = 0.0174; sensitivity 59.25%, specificity 84%) had prognostic properties for persistent NLR elevation. Conclusions. The NLR decreases after TAVI, and this phenomenon is more evident in patients without AKI. Furthermore, baseline NLR cutoff values may be considered predictors of persistence of inflammatory response. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Surgical and transcatheter aortic valve replacement for severe aortic stenosis in low-risk elective patients: Analysis of the Aortic Valve Replacement in Elective Patients From the Aortic Valve Multicenter Registry.
- Author
-
Kowalówka, Adam R., Kowalewski, Mariusz, Wańha, Wojciech, Kołodziejczak, Michalina, Mariani, Silvia, Li, Tong, Pasierski, Michał, Łoś, Andrzej, Stefaniak, Sebastian, Malinowski, Marcin, Gocoł, Radoslaw, Hudziak, Damian, Bachowski, Ryszard, Wojakowski, Wojciech, Jemielity, Marek, Rogowski, Jan, Lorusso, Roberto, Suwalski, Piotr, and Deja, Marek
- Abstract
Transcatheter aortic valve implantation (TAVI) remains the preferred strategy for high-risk or elderly individuals with aortic valve (AV) stenosis who are not considered to be optimal surgical candidates. Recent evidence suggests that low-risk patients may benefit from TAVI as well. The current study evaluates midterm survival in low-risk patients undergoing elective surgical AV replacement (SAVR) versus TAVI. The Aortic Valve Replacement in Elective Patients From the Aortic Valve Multicenter Registry (AVALON) compared isolated elective transfemoral TAVI or SAVR with sternotomy or minimally invasive approach in low-risk individuals performed between 2015 and 2019. Propensity score matching was conducted to determine SAVR controls for TAVI group in a 1-to-3 ratio with 0.2 caliper. A total of 2393 patients undergoing elective surgery (1765 SAVR and 629 TAVI) with median European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) score 1.81 (interquartile range [IQR], 1.36 to 2.53]) were initially included. Median follow-up was 2.72 years (IQR, 1.32-4.08; max 6.0). Propensity score matching returned 329 TAVI cases and 593 SAVR controls. Thirty-day mortality was 11 out of 329 (3.32%) in TAVI and 18 out of 593 (3.03%) in SAVR (risk ratio, 1.10; 95% CI, 0.52-2.37; P =.801) groups, respectively. At 2 years, survival curves began to diverge in favor of SAVR, which was associated with 30% lower mortality (hazard ratio, 0.70; 95% CI, 0.496-0.997; P =.048). Our data did not demonstrate a survival difference between TAVI and SAVR during the first 2 postprocedure years. After that time, SAVR is associated with improved survival. Extended observations from randomized trials in low-risk patients undergoing elective surgery are warranted to confirm these findings and draw definitive conclusions. [Display omitted] [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Association between time-related changes in routine blood morphological parameters and renal function after transcatheter aortic valve implantation - a preliminary study.
- Author
-
Stelmark, Konrad, Zaher, Eli Adrian, Olasińska-Wiśniewska, Anna, Adesina, Michael, Dragone, Alicia, Isaac, Martha, Misterski, Marcin, Grygier, Marek, Puślecki, Mateusz, Lesiak, Maciej, Jemielity, Marek, and Perek, Bartłomiej
- Subjects
HEART valve prosthesis implantation ,KIDNEY physiology ,ACUTE kidney failure ,NEUTROPHIL lymphocyte ratio ,INFLAMMATION - Abstract
Introduction: Transcatheter aortic valve implantation (TAVI) although minimally invasive is still accompanied by changes in blood morphological parameters, some of them linked to unfavorable outcomes. Aim: To find any association between changes in blood morphology reflecting an inflammatory response and acute kidney injury (AKI). Material and methods: This study involved 176 consecutive transfemoral TAVI patients with a mean age of 78.4 ±7.0 years. Serum creatinine concentration (CREA) and blood morphology were analyzed in the blood samples taken before the procedure, then approximately 1, 24, 48 and 72 hours after the procedure, and lastly at the time of discharge. Post-procedural maximal or minimal values (max/min) and max/min-to-bs ratio of the laboratory parameters were also calculated. Results: Leucocyte (WBC) and neutrophil (NEUT) counts increased significantly after the procedure whereas lymphocyte (LYMPH) counts declined markedly, reaching the highest or lowest values 24 hours after the procedure. A significant increase in neutrophil-to-lymphocyte ratio (NLR) was observed. Platelet count (PLT) dropped to a minimum at 72 hours after TAVI but at discharge did not return to the admission level. TAVI was associated with a marked increase in CREA with a peak at 48 hours after the procedure (135.7 ±75.9 µM/l). Patients with AKI (n = 65; 36.9%) presented more pronounced variations in relative changes in counts of all blood morphological parameters. A positive moderate (r = 0.412) correlation between maximal NLR and relative CREA changes was noted. Conclusions: TAVI is associated with significant changes in blood morphological parameters that reflect an inflammatory response. They are more pronounced among subjects with post-procedural AKI. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Late subclinical hemolysis and long-term outcomes after aortic valve replacement with On-X mechanical prostheses - a preliminary single-center report.
- Author
-
Perek, Bartłomiej, Sławek, Sylwia, Malińska, Agnieszka, Katyńska, Izabela, Puślecki, Mateusz, Szymak-Pawełczyk, Bogumiła, Nowicki, Michał, and Jemielity, Marek
- Subjects
HEMOLYSIS & hemolysins ,AORTIC valve surgery ,ARTIFICIAL implants - Abstract
Copyright of Polish Journal of Thoracic & Cardiovascular Surgery / Kardiochirurgia i Torakochirurgia Polska is the property of Termedia Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2017
- Full Text
- View/download PDF
10. Transapical aortic valve implantation using a Symetis Acurate self-expandable bioprosthesis: initial outcomes of 10 patients.
- Author
-
Misterski, Marcin, Puślecki, Mateusz, Grygier, Marek, Olasińska-Wiśniewska, Anna, Lesiak, Maciej, Araszkiewicz, Aleksander, Perek, Barłomiej, Choręziak, Aneta, Lindner, Jacek, Komosa, Anna, Buczkowski, Piotr, Ligowski, Marcin, Katarzyński, Sławomir, and Jemielity, Marek
- Subjects
AORTIC valve transplantation ,BIOPROSTHESIS ,AORTIC stenosis ,CARDIAC pacemakers ,HEART valve diseases - Abstract
Introduction: Transapical aortic valve implantation (TA-AVI) has been widely introduced for treatment of patients with severe aortic stenosis in the last decade. Here we report our first clinical experience with 10 patients using the second-generation transapical Symetis Acurate TA aortic valve designed for transapical implantation. Aim: To evaluate the results of transapical access in transcatheter aortic valve implantation (TAVI) among patients with unsuitable vascular access. Material and methods: All patients had been assessed by a local heart team and were disqualified from surgical aortic valve replacement (AVR) and the transfemoral TAVI approach. Mean age was 75.4 ±3.9 years (range: 68-80), with 20% being female. Logistic EuroSCORE (European System for Cardiac Operative Risk Evaluation) and STS (Society of Thoracic Surgeons) were 15.4 ±8.9% and 20.5 ±4.5%, respectively. Results: All implantations were performed successfully in the intra-annular and subcoronary position. There were no conversions to surgical AVR. All patients survived 30-day follow-up. No strokes or transient ischemic attacks were reported. There was no need for pacemaker implantation and none of the patients demonstrated moderate or significant paravalvular leakage. The mean aortic gradients improved significantly from a baseline of 57.0 ±19.2 mm Hg to a 30-day value of 14.2 ±4.1 mm Hg. Conclusions: Our initial clinical results indicate satisfactory functionality in patients after trans-apical implantation of the Symetis Acurate aortic valve. The procedure of implantation seems to be straightforward and may be considered in patients in whom a transfemoral approach is not a good option. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Femoral artery anatomy-tailored approach in transcatheter aortic valve implantation.
- Author
-
Olasińska-Wiśniewska, Anna, Grygier, Marek, Lesiak, Maciej, Araszkiewicz, Aleksander, Trojnarska, Olga, Komosa, Anna, Misterski, Marcin, Jemielity, Marek, Proch, Marek, and Grajek, Stefan
- Subjects
FEMORAL artery ,AORTIC valve surgery ,SURGICAL complications ,HOSPITAL mortality ,DISEASE incidence ,ANATOMY - Abstract
Introduction: The best techniques for reduction of femoral access site complications after transcatheter aortic valve implantation (TAVI) remain the object of research. Aim: We report on a single center's experience with TAVI performed via the femoral access site. Material and methods: Between September 2010 and September 2015, 152 consecutive patients underwent TAVI in our department. Of them, 101 patients with CoreValve implantation from the femoral access site were included in the analysis. The femoral artery anatomy-tailored approach was introduced in 2013 in order to reduce the rate of access-site complications. Patients were assigned to percutaneous puncture or surgical cut-down depending on the femoral artery anatomy assessed in computed tomography. The study patients were divided into two subgroups: group A - patients treated before January 2013, before introduction of the tailored approach program (n = 34); and group B - patients treated between January 2013 and April 2015 (n = 67). Results: The access site complication rate significantly decreased from 35.3% in group A (n = 12) to 7.5% in group B (n = 5) (p = 0.0012). Both minor and major access site complications were more frequent in group A (p = 0.04 and 0.016, respectively). In-hospital mortality was 8.8% (n = 3) in group A and 1.5% (n = 1) in group B (p = 0.1). Conclusions: The femoral artery anatomy-tailored approach significantly reduces the incidence of access site complications in TAVI patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
12. Monocyte-to-lymphocyte ratio correlates with parathyroid hormone concentration in patients with severe symptomatic aortic stenosis.
- Author
-
Olasińska-Wiśniewska, Anna, Urbanowicz, Tomasz, Grodecki, Kajetan, Kübler, Piotr, Perek, Bartłomiej, Grygier, Marek, Misterski, Marcin, Walczak, Maciej, Szot, Mateusz, and Jemielity, Marek
- Subjects
- *
MONOCYTE lymphocyte ratio , *AORTIC stenosis , *PLATELET lymphocyte ratio , *PARATHYROID hormone , *LOGISTIC regression analysis - Abstract
The normal healthy valve is devoid of inflammatory cells, however background of aortic stenosis (AS) may include inflammatory processes. Moreover, the link between hyperparathyroidism and heart failure is postulated. Simple whole blood analysis with indices is a beneficial tool in cardiovascular diseases' assessment. The purpose of the study was to evaluate correlation between parathyroid hormone (PTH) and simple blood parameters in severe AS. The study included 62 patients with severe AS. Patients with inflammatory or autoimmune co-morbidities were excluded. Blood samples were collected, and clinical and demographic data were analyzed. The final study group comprised 55 patients (31 females, 56.4%; mean age 77.13 (SD 6.76)). In 23 patients (41.8%), PTH concentration was markedly increased. The study group was divided into two subgroups according to the PTH concentration. Patients from both groups did not differ significantly in terms of age and co-morbidities. PTH concentration correlated positively with monocyte-lymphocyte ratio (MLR) (p = 0.008, Spearman rho 0.356) and platelet-lymphocyte ratio (PLR) (p = 0.047, Spearman rho 0.269), creatinine level (p = 0.001, Spearman rho 0.425) and glomerular filtration rate (GFR-MDRD) (p = 0.009, Spearman rho −0.349). The multivariable logistic regression with backward analysis revealed MLR (p = 0.029) and GFR (p = 0.028) as independent significant predictors of abnormal PTH values. The receiver operator characteristics (ROC) curve was performed for the model of MLR and GFR-MDRD (AUC = 0.777), yielding the sensitivity of 60.9% and specificity of 90.6%. PTH concentration correlates with monocyte-to-lymphocyte and platelet-to-lymphocyte ratios in calcified AS. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.